PEOPLE ON THE MOVE
AXIM Biotechnologies calls Emil Engels to Advisory Board
AXIM Biotechnologies Inc. appointed Emil Engels to their advisory board on December 20.
Formerly AXIM International Inc., the New York firm is conducting trials to deliver small molecule APIs via a chewing gum to treat a range of indications such as Crohn’s, Parkinson’s and Multiple Sclerosis.
Engels is an American anaesthesiologist who serves as Corporate Compliance Officer for Fairfax Anesthesiology Associates, where he is a partner. He also serves on the Mednax Corporate Coding and Compliance Committees and other ASA committees.
Engel is also the current President-Elect of the Virginia Society of Anesthesiologists (VSA) and participates on the Medicare Carrier Advisory Committee for Novitas.
